• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GE Liang, LU Man, CHEN Yue-jian, CHEN Yan-hua. In vitro release and the liver targeting of oxymatrine polybutylcyanoacrylate nanoparticles[J]. Journal of China Pharmaceutical University, 2010, 41(6): 520-523.
Citation: GE Liang, LU Man, CHEN Yue-jian, CHEN Yan-hua. In vitro release and the liver targeting of oxymatrine polybutylcyanoacrylate nanoparticles[J]. Journal of China Pharmaceutical University, 2010, 41(6): 520-523.

In vitro release and the liver targeting of oxymatrine polybutylcyanoacrylate nanoparticles

More Information
  • Oxymatrine (OM) polybutylcyanoacrylate nanoparticles (OM-PBCA-NP) was prepared,and in vitro release of OM-PBCA-NP as well as the liver targeting potentials of OM-PBCA-NP and oxymatrine solution (OM-SOL) were studied in mice. It was found that 100% of OM was released from OM solution in 4 h,but only 36.73% from OM-PBCA-NP. In the study of tissue distribution of OM-PBCA-NP,there existed 8.338-fold increase in the area under the liver concentration-time curve in comparison to that of OM-SOL. Hence,OM-PBCA-NP sustained drug release and increased the liver targeting significantly.
  • Related Articles

    [1]WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405
    [2]YONG Qin, YUE Hanxun, SHI Min, HUANG Shiqin, ZHAO Xuan, YU Xian. Construction and in vitro evaluation of pH-responsive and tumor-targeted PTEN/PLGA-(HE)10-MAP nanoparticles[J]. Journal of China Pharmaceutical University, 2021, 52(3): 301-310. DOI: 10.11665/j.issn.1000-5048.20210306
    [3]WANG Xue, YANG Tingting, JIANG Zhenzhou, ZHANG Luyong. Tight junctions-associated proteins:a novel therapeutic target for cholestatic liver injury[J]. Journal of China Pharmaceutical University, 2019, 50(2): 143-151. DOI: 10.11665/j.issn.1000-5048.20190203
    [4]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [5]ZHANG Wenzheng, YANG Yang, CHEN Ya, XIAO Tao, FU Xiaozhong, DONG Yongxi. Synthesis and bioactivity of mixed phosphonate derivatives of adefovir with hepatic targeting property[J]. Journal of China Pharmaceutical University, 2018, 49(1): 39-47. DOI: 10.11665/j.issn.1000-5048.20180106
    [6]BIAN Li, GAO Meng, HUANG Dejian, PENG Fei, ZHANG Jian, YIN Zhiqi. Synthesis and necrosis target of necrosis-avid MRI contrast agent Gd-DO3A-rhein[J]. Journal of China Pharmaceutical University, 2017, 48(3): 282-288. DOI: 10.11665/j.issn.1000-5048.20170305
    [7]GAO Yuanyue, LIU Aiyun, SHEN Jiajia, DING Ya. Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2016, 47(5): 537-542. DOI: 10.11665/j.issn.1000-5048.20160505
    [8]DING Lu, YANG Jiapei, SUN Hao, ZHOU Wang, YU Feng. Viability assessment for liver perfusion models of rats[J]. Journal of China Pharmaceutical University, 2014, 45(4): 475-479. DOI: 10.11665/j.issn.1000-5048.20140416
    [9]Preparation and Characterization of Novel Galactosylated Chitosan[J]. Journal of China Pharmaceutical University, 2003, (5): 1-4.
    [10]The Research on Liver Targeting Delivery System of Cantharidin Polyphase Liposome Modified by Strengthened Targeting Material[J]. Journal of China Pharmaceutical University, 1998, (6): 413-417.

Catalog

    Article views (1368) PDF downloads (1824) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return